Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GARDASIL
- Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
- Gardasil Versus Cervarix in the Treatment of Warts
- Assessing Durable Antibody Response to HPV Vaccination
- A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
- An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
- Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
- HPV-SAVE: 9-Valent HPV Vaccine for High-Grade Anal Dysplasia
- Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9
- A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
- Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
- HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
- Adolescent Vaccination in Pharmacies
- Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
- A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
- The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
- Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
- Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Clinical trials list
click for details